Quote MS11172022 this project is necessary for CDS because without IT the a whole part of the integrative approach used by CDS will not be possible; IT will not be possible to investigate genetic…
Ended Purchase Order Awarded Last action
- Contract number
- 75N92E23P00046
- Awardee
-
Reprocell U.s.a., Inc. UEI F1KBMX8JQ385
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,017
Award facts
- Contract value 100% obligated
- $17,016.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Calverton, MD 20705, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research approach. Reprocell U.S.A., Inc. is a for-profit organization specializing in advanced biological research services such as laboratory testing and material extraction. The contract was awarded through full and open competition with no set-aside designation, indicating Reprocell's competitive position in providing specialized scientific support to federal research institutions.
Description
Quote MS11172022 this project is necessary for CDS because without IT the a whole part of the integrative approach used by CDS will not be possible; IT will not be possible to investigate genetic and epigenetic effect at transcriptome level
Quick answers
Who was awarded contract 75N92E23P00046?
75N92E23P00046 was awarded to Reprocell U.s.a., Inc. by National Human Genome Research Institute (National Institutes of Health) on January 5, 2023.
How much is contract 75N92E23P00046 worth?
The government has obligated $17,017 on 75N92E23P00046.
Was contract 75N92E23P00046 competed?
The extent of competition for 75N92E23P00046 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award